Summary:
- Researchers are using artificial intelligence (AI) to design new antibodies that could be used as treatments for various diseases.
- The AI-designed antibodies are showing promising results in early laboratory tests and are now moving towards clinical trials in humans.
- This technology could lead to the development of more effective and targeted treatments for a wide range of health conditions, including cancer, infectious diseases, and autoimmune disorders.